NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its first-quarter revenues swelled 12 percent year over year, or 9 percent on a currency-neutral basis, driven largely by a 10 percent spike in its diagnostics sales, while revenues from the BD Biosciences segment were flat.

The Franklin Lakes, NJ-based maker of diagnostics, medical products, and life science research tools reported revenues of $1.9 billion for the three-month period ended December 31, up from revenues of $1.7 billion in the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.